Polipharm Co., Ltd. held a scientific conference on the topic of “Empabit - SGLT2 inhibitor,” a new and accessible option for diabetic patients, on Tuesday, May 26, 2026, from 5:00 PM to 8:00 PM at Asia Hotel.

The company was honored to have distinguished speakers present on academic topics that are beneficial to the development of knowledge and practice guidelines in pharmacy, as follows:

• 5:30 PM – 6:00 PM: Empagliflozin: It’s pharmacology beyond antihyperglycemia

        by Assoc. Prof. Dr. Chuthamanee Sutthisisang

• 6:00 PM – 6:30 PM: Ensuring Generic Drug Quality: Specification and Beyond

        by Assoc. Prof. Dr. Worasit Wongsutthilert

• 6:30 PM – 6:45 PM: Polipharm’s Quality System

        by Pharmacist Wanna Thanesanont.

Forty pharmacists from 24 hospitals in Bangkok and surrounding areas attended the meeting to receive academic information, follow up on treatment advancements, and exchange knowledge about criteria for selecting quality medications, which will be beneficial to their practice in the pharmacy profession.